The rise of blockbuster pharmaceutical acquisitions has prompted fears that unprecedented market concentration will weaken competition. Two of the most prominent concerns focus on the upstream and downstream ends of the pharmaceutical industry: (1) the concern that these mergers will concentrate...

We examine the implications of pre-grant publication (PP) of patent applications in the context of a cumulative innovation model. We show that pre-grant publication of patents lead to fewer applications and fewer inventions, but it raises the probability that new technologies will reach the...